Windsor Clinical Research, Inc /ID# 153877

The trials here

What the trial at this site is about, from its registry record.

Conditions

• Psoriasis

Closed trials

• Completed

  A Study to Assess the Safety and Efficacy of Risankizumab for Maintenance in Moderate to Severe Plaque Type Psoriasis ( LIMMITLESS )

  NCT03047395· Phase 3· AbbVie· Source